Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.

Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.

Item
http://www.wikidata.org/entity/Q34073821
Selective Insulin Resistance in the KidneyThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyAsparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)Insulin-like growth factor-1 deficiency and metabolic syndromeThe Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated ProteinsEvolution of the vertebrate insulin receptor substrate (Irs) gene familyMiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.Global Phosphoproteomic Analysis of Insulin/Akt/mTORC1/S6K Signaling in Rat Hepatocytes.Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.Upregulation of AKT3 Confers Resistance to the AKT Inhibitor MK2206 in Breast Cancer.TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling.Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.Commentary: IL-4 and IL-13 receptors and signalingLong Noncoding RNA H19 Inhibits Cell Viability, Migration, and Invasion Via Downregulation of IRS-1 in Thyroid Cancer Cells.Identification of a novel invasion-promoting region in Insulin Receptor Substrate 2 (IRS2).IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
P2860

Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.

Item
http://www.wikidata.org/entity/Q34073821
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@ast
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@en
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@nl
type
label
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@ast
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@en
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@nl
prefLabel
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@ast
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@en
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Insulin receptor substrate 2-m ...... o regulate aerobic glycolysis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932